Letter | Published:

Isolation from Bordetella pertussis of Protective Antigen free from Toxic Activity and Histamine Sensitizing Factor

Naturevolume 214pages9697 (1967) | Download Citation



IN view of the untoward reactions which pertussis vaccine occasionally produces in vaccinated children, the importance is now generally recognized of developing a vaccine with protective properties yet free from those factors responsible for reactions. van Hemert, van Wezel and Cohen1 described a method of extracting the protective antigen from Bordetella pertussis by treating a suspension of the organisms with Na-deoxycholate and then with DNase and RNase. This treatment was followed by gel-filtration to remove the Na-deoxycholate together with other low molecular weight compounds. The resulting extract, SDE, contained the protective antigen but also toxic factors. Further experiments have now been made, which are reported below, to obtain the protective antigen free from toxic factors.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    van Hemert, P. A., van Wezel, A. L., and Cohen, H. H., Nature, 203, 774 (1964).

  2. 2

    World Health Organization, Tech. Rep. Ser., 274 (1964).

  3. 3

    Parfentjev, I. A., Goodline, M. A., and Virion, M. E., J. Bact., 53, 597, 603, 613 (1947).

  4. 4

    Preston, N. W., J. Path. Bact., 78, 217 (1959).

  5. 5

    Cohen, H. H., Anthonie van Leeuwenhoek, 29, 183 (1963).

Download references

Author information


  1. Immunochemistry Department, Rijks Instituut voor Volksgesondheid, Bilthoven, The Netherlands

    • J. NAGEL


  1. Search for J. NAGEL in:

About this article

Publication history


Issue Date




By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.